We are live on ! Find out more
BG

Bellevue Group Portfolio holdings

AUM $4.2B
1-Year Est. Return 54.85%
This Fund
S&P 500
This Quarter Est. Return
+16.89%
1 Year Est. Return
+54.85%
3 Year Est. Return
+140.3%
5 Year Est. Return
+171.01%
10 Year Est. Return
+915.55%
AUM
$1.82B
AUM Growth
+$296M
Cap. Flow
+$80.3M
Cap. Flow %
4.42%
Top 10 Hldgs %
36.79%
Holding
155
New
17
Increased
81
Reduced
30
Closed
18

Top Buys

Rank Stock Value
1
EVH icon
Evolent Health
EVH
+$21.6M
2
HUM icon
Humana
HUM
+$21.3M
3
TDOC icon
Teladoc Health
TDOC
+$18.3M
4
BMY icon
Bristol-Myers Squibb
BMY
+$10.4M
5
AVDR
Avedro, Inc Common Stock
AVDR
+$9.38M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$56M
2
AMGN icon
Amgen
AMGN
+$5.81M
3
BIIB icon
Biogen
BIIB
+$5.29M
4
IONS icon
Ionis Pharmaceuticals
IONS
+$5.16M
5
MGNX icon
MacroGenics
MGNX
+$4.78M

Sector Composition

Rank Sector Weight
1 Healthcare 91.35%
2 Industrials 1.12%
3 Technology 0.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XENT
51
DELISTED
Intersect ENT, Inc
XENT
$10.6M 0.58%
328,387
+90,943
+38% +$2.81M
MOH icon
52
Molina Healthcare
MOH
$11.8B
$10.2M 0.56%
71,840
+16,456
+30% +$2.23M
SUPN icon
53
Supernus Pharmaceuticals
SUPN
$2.82B
$10.2M 0.56%
291,000
-54,100
-16% -$2.01M
CNC icon
54
Centene
CNC
$32.8B
$9.29M 0.51%
174,988
-5,214
-3% -$316K
AVDR
55
DELISTED
Avedro, Inc Common Stock
AVDR
$9.2M 0.51%
+750,000
New +$9.38M
OXFD
56
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$9.07M 0.5%
526,162
+219,556
+72% +$3.47M
QTRX icon
57
Quanterix
QTRX
$181M
$9.02M 0.5%
349,359
+63,452
+22% +$1.42M
IRTC icon
58
iRhythm Holdings
IRTC
$3.64B
$8.83M 0.49%
117,761
+33,969
+41% +$2.9M
COO icon
59
Cooper Companies
COO
$13.9B
$8.77M 0.48%
118,476
– –
HMSY
60
DELISTED
HMS Holdings Corp.
HMSY
$8.62M 0.47%
290,977
+74,160
+34% +$2.29M
GH icon
61
Guardant Health
GH
$20.5B
$8.41M 0.46%
109,652
+535
+0.5% +$29.7K
REGN icon
62
Regeneron Pharmaceuticals
REGN
$70.6B
$8.38M 0.46%
20,400
+5,200
+34% +$2.14M
TNDM icon
63
Tandem Diabetes Care
TNDM
$1.15B
$8.1M 0.45%
127,541
+28,288
+29% +$1.49M
NVRO
64
DELISTED
NEVRO CORP.
NVRO
$8.03M 0.44%
128,402
+46,964
+58% +$2.21M
HCA icon
65
HCA Healthcare
HCA
$82.9B
$7.88M 0.43%
60,397
+13,363
+28% +$1.79M
QTNT
66
DELISTED
Quotient Limited Ordinary Shares
QTNT
$7.16M 0.39%
19,877
-963
-5% -$339K
INSP icon
67
Inspire Medical Systems
INSP
$1.47B
$6.99M 0.38%
123,105
+30,489
+33% +$1.65M
CSLT
68
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$6.83M 0.38%
1,820,470
+760,955
+72% +$2.42M
INGN icon
69
Inogen
INGN
$176M
$6.65M 0.37%
69,727
+36,435
+109% +$4.54M
VEEV icon
70
Veeva Systems
VEEV
$31.2B
$6.61M 0.36%
52,110
+14,018
+37% +$1.58M
TRHC
71
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$6.51M 0.36%
115,462
+27,605
+31% +$1.64M
IDXX icon
72
Idexx Laboratories
IDXX
$44.6B
$6.13M 0.34%
27,402
+3,095
+13% +$639K
TFX icon
73
Teleflex
TFX
$5.9B
$5.97M 0.33%
19,748
– –
RMD icon
74
ResMed
RMD
$28.4B
$5.68M 0.31%
54,667
-725
-1% -$74.8K
XRAY icon
75
Dentsply Sirona
XRAY
$2.78B
$5.5M 0.3%
110,878
– –
1 2
3
4 5

Similar funds

WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.2B AUM 18.37% 1-Year Est. Return
AC
AlphaCore Capital La Jolla, California $4.22B AUM 21.28% 1-Year Est. Return
HIP
HUB Investment Partners Austin, Texas $4.18B AUM 24.76% 1-Year Est. Return
DT
DV Trading Chicago, Illinois $4.22B AUM
ATPW
Ashton Thomas Private Wealth Scottsdale, Arizona $4.23B AUM 20.9% 1-Year Est. Return
BT
Banque Transatlantique Paris, France $4.17B AUM 28.5% 1-Year Est. Return
NCM
Nearwater Capital Markets Dublin 4, Dublin, Ireland $4.24B AUM 66.03% 1-Year Est. Return
MSU
Mizuho Securities USA New York $4.24B AUM 23.1% 1-Year Est. Return

Bellevue Group's Q1 2019 Portfolio in Review

As of Q1 2019, Bellevue Group held 155 positions worth $1.82B, up 19% from $1.52B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Bellevue Group deployed $80.3M of net new capital in Q1 2019, opening 17 new positions and adding to 81 existing holdings. Its largest new stake was Avedro, Inc Common Stock: 750,000 shares worth $9.2M.

By sector, the portfolio is most concentrated in Healthcare at 91% of assets, up from 88% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Celgene Corp, an estimated $56M trimmed.

  • Bellevue Group's largest Q1 2019 buy was Avedro, Inc Common Stock: 750,000 shares worth $9.2M.
  • Bellevue Group added most to Evolent Health in Q1 2019, an estimated $21.6M increase.
  • Bellevue Group's biggest Q1 2019 reduction was Celgene Corp, cutting an estimated $56M.
  • Bellevue Group fully exited BioMarin Pharmaceuticals in Q1 2019, selling an estimated $3.91M.
  • Bellevue Group's ten largest holdings make up 37% of its $1.82B portfolio in Q1 2019.
  • Bellevue Group opened 17 new positions and closed 18 in Q1 2019.
  • Bellevue Group's portfolio value rose 19% quarter-over-quarter to $1.82B.

Based on Bellevue Group's 13F filing for Q1 2019, filed 15 May 2019.